BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37748197)

  • 1. Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region.
    Becerra-Canales B; Campos M; Atuncar-Deza S; Cáceres-Yparraguirre H
    Medwave; 2023 Sep; 23(8):. PubMed ID: 37748197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
    Suk R; Hong YR; Rajan SS; Xie Z; Zhu Y; Spencer JC
    JAMA Netw Open; 2022 Jan; 5(1):e2143582. PubMed ID: 35040970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How does type of health insurance affect receipt of Pap testing in Peru?].
    Barrionuevo-Rosas L; Palència L; Borrell C
    Rev Panam Salud Publica; 2013 Dec; 34(6):393-400. PubMed ID: 24569967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique.
    Brandão M; Tulsidás S; Damasceno A; Silva-Matos C; Carrilho C; Lunet N
    Eur J Cancer Prev; 2019 Jul; 28(4):338-343. PubMed ID: 30020115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening coverage in a high-incidence region.
    Navarro C; Fonseca AJ; Sibajev A; Souza CI; Araújo DS; Teles DA; Carvalho SG; Cavalcante KW; Rabelo WL
    Rev Saude Publica; 2015; 49():17. PubMed ID: 25741655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.
    Hosier H; Sheth SS; Oliveira CR; Perley LE; Vash-Margita A
    Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
    Johnson NL; Head KJ; Scott SF; Zimet GD
    Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between knowledge about cervical cancer and having a Papanicolaou test in peruvian women.
    Bendezu-Quispe G; Soriano-Moreno AN; Urrunaga-Pastor D; Venegas-Rodríguez G; Benites-Zapata VA
    Rev Peru Med Exp Salud Publica; 2020; 37(1):17-24. PubMed ID: 32520183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
    Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
    BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    Touch S; Oh JK
    BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's knowledge and attitudes towards cervical cancer prevention: A qualitative study in the Spanish context.
    Borrull-Guardeño J; Sebastiá-Laguarda C; Donat-Colomer F; Sánchez-Martínez V
    J Clin Nurs; 2021 May; 30(9-10):1383-1393. PubMed ID: 33528874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study.
    Ruddies F; Gizaw M; Teka B; Thies S; Wienke A; Kaufmann AM; Abebe T; Addissie A; Kantelhardt EJ
    BMC Cancer; 2020 Jun; 20(1):563. PubMed ID: 32552740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study.
    Bao H; Ma L; Zhao Y; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wu J; Wang HJ
    Cancer Commun (Lond); 2022 Mar; 42(3):191-204. PubMed ID: 35142100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of a cervical cancer screening program via co-testing at a university hospital.
    Denninghoff V; von Petery F; Fresno C; Galarza M; Torres F; Avagnina A; Fishkel V; Krupitzki H; Fiorillo A; Monge F
    PLoS One; 2022; 17(12):e0278476. PubMed ID: 36454784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.